PARP3 comes to light as a prime target in cancer therapy

Volume: 18, Issue: 12, Pages: 1295 - 1301
Published: May 29, 2019
Abstract
Poly(ADP-ribose) polymerase 3 (PARP3) is the third member of the PARP family that catalyze a post-translational modification of proteins to promote, control or adjust numerous cellular events including genome integrity, transcription, differentiation, cell metabolism or cell death. In the late years, PARP3 has been specified for its primary functions in programmed and stress-induced double-strand break repair, chromosomal rearrangements,...
Paper Details
Title
PARP3 comes to light as a prime target in cancer therapy
Published Date
May 29, 2019
Journal
Volume
18
Issue
12
Pages
1295 - 1301
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.